History of diabetes mellitus and the risk of prostate cancer: The Ohsaki Cohort Study

Cancer Causes and Control

Volumn 21, Issue 7, 2010, Pages 1025-1032

  Li, Qiang ^a,b   Kuriyama, Shinichi ^a   Kakizaki, Masako ^a   Yan, Hong ^b   Sone, Toshimasa ^a   Nagai, Masato ^a   Sugawara, Yumi ^a   Ohmori Matsuda, Kaori ^a   Hozawa, Atsushi ^a   Nishino, Yoshikazu ^c   Tsuji, Ichiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Diabetes mellitus; Incidence; Japan; Prospective studies; Prostatic neoplasms

Indexed keywords

GLUCOSE;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILY HISTORY; GLUCOSE BLOOD LEVEL; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; SELF REPORT; SLEEP; SLEEP DURATION; SMOKING; WALKING;

AGED; COHORT STUDIES; DIABETES MELLITUS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 77955710301     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9530-9     Document Type: Article

References (42)

1. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431
2. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053
3. Quinn M, Babb P (2002) Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int 90:162-173
4. Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H (2000) Trends and characteristics in prostate cancer mortality in Japan. Int J Urol 7:254-257
5. The Editorial Board of the Cancer Statistics in Japan (2005) Cancer Statistics in Japan edition. Foundation for Promotion of Cancer Research, Tokyo
6. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108
7. Waters KM, Henderson BE, Stram DO, Wan P, Kolonel LN, Haiman CA (2009) Association of diabetes with prostate cancer risk in the multiethnic cohort. Am J Epidemiol 169:937-945
8. Kasper JS, Liu Y, Giovannucci E (2009) Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 124:1398-1403
9. Velicer CM, Dublin S, White E (2007) Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications. Prostate Cancer Prostatic Dis 10:46-51
10. Calton BA, Chang SC, Wright ME, Kipnis V, Lawson K, Thompson FE, Subar AF, Mouw T, Campbell DS, Hurwitz P, Hollenbeck A, Schatzkin A et al (2007) History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control 18:493-503
11. Rodriguez C, Patel AV, Mondul AM, Jacobs EJ, Thun MJ, Calle EE (2005) Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol 161:147-152
12. Weiderpass E, Ye W, Vainio H, Kaaks R, Adami HO (2002) Reduced risk of prostate cancer among patients with diabetes mellitus. Int J Cancer 102:258-261
13. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1998) Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control 9:3-9
14. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, Borch-Johnsen K, Olsen JH (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89:1360-1365
15. Leitzmann MF, Ahn J, Albanes D, Hsing AW, Schatzkin A, Chang SC, Huang WY, Weiss JM, Danforth KN, Grubb RL III, Andriole GL (2008) Diabetes mellitus and prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Causes Control 19:1267-1276
16. Will JC, Vinicor F, Calle EE (1999) Is diabetes mellitus associated with prostate cancer incidence and survival? Epidemiology 10:313-318
17. Steenland K, Nowlin S, Palu S (1995) Cancer incidence in the National Health, Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev 4:807-811
18. Thompson MM, Garland C, Barrett-Connor E, Khaw KT, Friedlander NJ, Wingard DL (1989) Heart disease risk factors, diabetes, and prostatic cancer in an adult community. Am J Epidemiol 129:511-517
19. Ragozzino M, Melton LJ III, Chu CP, Palumbo PJ (1982) Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35:13-19
20. Tsuji I, Nishino Y, Ohkubo T, Kuwahara A, Ogawa K, Watanabe Y, Tsubono Y, Bando T, Kanemura S, Izumi Y, Sasaki A, Fukao A et al (1998) A prospective cohort study on National Health Insurance beneficiaries in Ohsaki, Miyagi Prefecture, Japan: study design, profiles of the subjects and medical cost during the first year. J Epidemiol 8:258-263
21. Tsuji I, Kuwahara A, Nishino Y, Ohkubo T, Sasaki A, Hisamichi S (1999) Medical cost for disability: a longitudinal observation of national health insurance beneficiaries in Japan. J Am Geriatr Soc 47:470-476
22. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I (2006) Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296:1255-1265
23. Kakizaki M, Inoue K, Kuriyama S, Sone T, Matsuda-Ohmori K, Nakaya N, Fukudo S, Tsuji I (2008) Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study. Br J Cancer 99:176-178
24. Li Q, Kakizaki M, Kuriyama S, Sone T, Yan H, Nakaya N, Mastuda-Ohmori K, Tsuji I (2008) Green tea consumption and lung cancer risk: the Ohsaki study. Br J Cancer 99:1179-1184
25. Ogawa K, Tsubono Y, Nishino Y, Watanabe Y, Ohkubo T, Watanabe T, Nakatsuka H, Takahashi N, Kawamura M, Tsuji I, Hisamichi S (2003) Validation of a food-frequency questionnaire for cohort studies in rural Japan. Public Health Nutr 6:147-157
26. Takano A, Okuno Y (1997) Japan, Miyagi Prefecture. In: Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds) Cancer incidence in five continents, vol.7. IARC Sci Publ., Paris, pp 386-389
27. Percy C, Holton VV (1990) International classification of diseases for oncology, 2nd edn. World Health Organization, Geneva
28. Mishina T, Watanabe H, Araki H, Nakao M (1985) Epidemiological study of prostatic cancer by matched-pair analysis. Prostate 6:423-436
29. Cohen P, Peehl DM, Lamson G, Rosenfeld RG (1991) Insulinlike growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 73:401-407
30. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey JV Jr et al (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149(461- 471):W83-W88
31. Hsing AW, Gao YT, Chua S Jr, Deng J, Stanczyk FZ (2003) Insulin resistance and prostate cancer risk. J Natl Cancer Inst 95:67-71
32. Zamboni PF, Simone M, Passaro A, Doh Dalla Nora E, Fellin R, Solini A (2003) Metabolic profile in patients with benign prostate hyperplasia or prostate cancer and normal glucose tolerance. Horm Metab Res 35:296-300
33. Singh G, Lakkis CL, Laucirica R, Epner DE (1999) Regulation of prostate cancer cell division by glucose. J Cell Physiol 180: 431-438
34. Seki A, Takigawa T, Ito T, Fukuoka E, Takahashi K, Kira S (2002) Obesity and the risk of diabetes mellitus in middle-aged Japanese men. Acta Med Okayama 56:255-260
35. Porter MP, Stanford JL (2005) Obesity and the risk of prostate cancer. Prostate 62:316-321
36. Robinson WR, Stevens J, Gammon MD, John EM (2005) Obesity before age 30 years and risk of advanced prostate cancer. Am J Epidemiol 161:1107-1114 37. Bradbury BD, Wilk JB, Kaye JA (2005) Obesity and the risk of
37. Bradbury BD, Wilk JB, Kaye JA (2005) Obesity and the risk of prostate cancer (United States). Cancer Causes Control 16: 637-641.
38. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, Lippman SM, Platz EA, Pollak MN, Thompson IM, Kristal AR (2006) Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 15:1977-1983
39. Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV, Thun MJ, Calle EE (2007) Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 16:63-69
40. Wakai K (2005) Descriptive epidemiology of prostate cancer in Japan and Western countries. Nippon Rinsho 63:207-212
41. Akazawa Y (1994) Prevalence and incidence of diabetes mellitus by WHO criteria. Diabetes Res Clin Pract 24(Suppl):S23-S27
42. Nakano T, Ito H (2007) Epidemiology of diabetes mellitus in old age in Japan. Diabetes Res Clin Pract 77(Suppl 1):S76-S81